Malignant phyllodes tumour with spinal metastasis presenting as cauda equina syndrome.

BMJ Case RepOct 1, 2026 (epub)

Osman Mahboob, Yujin Suk, Mona Bishara et al.

✦ AI-curated · Sources linked

Case in brief

A female in her early 50s with a history of borderline phyllodes tumour underwent right mastectomy and adjuvant radiotherapy. Two years later, she presented with progressive lower back and bilateral leg pain, which was found to be due to severe spinal canal compression from an L4 vertebral lesion, leading to cauda equina syndrome. Surgical intervention included decompression, biopsy, and spinal fusion, confirming metastatic malignant phyllodes tumour.

What made this case unusual

Spinal metastases from malignant phyllodes tumours are exceptionally rare, with few cases documented in the literature.

Diagnostic / clinical pearl

Clinicians should consider spinal metastases in patients with a history of phyllodes tumour who present with back pain, as this can indicate aggressive disease progression.

Why it matters

Recognizing the potential for distant metastasis in malignant phyllodes tumours is crucial for timely diagnosis and management, particularly in atypical presentations.

Source

Published in BMJ Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.